NCT04052711View on ClinicalTrials.gov

A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design

PHASE1CompletedINTERVENTIONAL
Enrollment

233

Participants

Timeline

Start Date

September 8, 2016

Primary Completion Date

November 19, 2016

Study Completion Date

December 19, 2016

Conditions
Healthy
Interventions
DRUG

FMX-101

All Listed Sponsors
lead

Vyne Therapeutics Inc.

INDUSTRY

NCT04052711 - A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design | Biotech Hunter | Biotech Hunter